{"disease":{"id":"human-papilloma-virus","name":"human papilloma virus"},"drugs":{"marketed":[{"drug_id":"vaccine-administration","indication_name":"Human Papillomavirus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vaccine Support Cp","generic_name":"Vaccine administration","company_name":"Women and Infants Hospital of Rhode Island","drug_phase":"marketed","molecular_target":"unknown","drug_class":"vaccine","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adult)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05365048","title":"Provider Recommendation and HPV Vaccination","phase":"NA","overall_status":"RECRUITING","enrollment_count":301201,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT01078220","title":"Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)","phase":"","overall_status":"COMPLETED","enrollment_count":189629,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05229679","title":"HPV-based Screening Among Women 23-29 Years of Age","phase":"NA","overall_status":"RECRUITING","enrollment_count":180000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04576962","title":"County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana","phase":"","overall_status":"COMPLETED","enrollment_count":122152,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT01567813","title":"Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)","phase":"","overall_status":"COMPLETED","enrollment_count":114035,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06831383","title":"The STOP-HPV Scale Up Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT05536674","title":"SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":55176,"lead_sponsor_name":"The Behavioural Insights Team","has_results":false},{"nct_id":"NCT01077856","title":"GARDASIL™ Vaccine Impact in Population Study (V501-033)","phase":"","overall_status":"COMPLETED","enrollment_count":54516,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05996783","title":"Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":48000,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT07259616","title":"Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities","phase":"","overall_status":"COMPLETED","enrollment_count":46079,"lead_sponsor_name":"Gynaecologisch Oncologisch Centrum Zuid","has_results":false},{"nct_id":"NCT04371887","title":"Comparing Strategies for Implementing Primary HPV Screening","phase":"NA","overall_status":"UNKNOWN","enrollment_count":45000,"lead_sponsor_name":"Chun Chao","has_results":false},{"nct_id":"NCT04679675","title":"Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":32771,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT06557954","title":"Cervical Cytology DNA Methylation for Cervical Cancer Screening","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT03180034","title":"Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":27945,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03726151","title":"Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs","phase":"NA","overall_status":"UNKNOWN","enrollment_count":17000,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04226313","title":"Self-sampling for Non-attenders to Cervical Cancer Screening","phase":"NA","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"The Institute of Molecular and Translational Medicine, Czech Republic","has_results":false},{"nct_id":"NCT04746872","title":"Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening","phase":"","overall_status":"COMPLETED","enrollment_count":14935,"lead_sponsor_name":"Abbott Molecular","has_results":false},{"nct_id":"NCT00543543","title":"Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14840,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07200414","title":"Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)","phase":"NA","overall_status":"COMPLETED","enrollment_count":12654,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT05932576","title":"A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women","phase":"","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT05668572","title":"A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Beijing Health Guard Biotechnology, Inc","has_results":false},{"nct_id":"NCT04646954","title":"DNA Methylation Testing for the Screening of Uterine Cervical Lesion","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT02733068","title":"A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12000,"lead_sponsor_name":"Shanghai Zerun Biotechnology Co.,Ltd","has_results":false},{"nct_id":"NCT05309122","title":"Cervical Cancer Screening Strategies","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06815939","title":"Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"DL Analytics","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT03961178","title":"A Cohort Study for the Following up of Conization","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05431699","title":"Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9100,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT00867464","title":"Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8670,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06810739","title":"The Women's Screening and Self-Testing Program (PROMETA) Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":8445,"lead_sponsor_name":"Tulane University","has_results":false},{"nct_id":"NCT04208269","title":"A Multilevel Approach to Increasing HPV Vaccine Initiation Among Adolescents - Part 3","phase":"NA","overall_status":"COMPLETED","enrollment_count":5663,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT05237947","title":"Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02653118","title":"Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4453,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT02135419","title":"Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4446,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT00090220","title":"A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3819,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01062074","title":"GARDASIL Reexamination Study (V501-059)","phase":"","overall_status":"COMPLETED","enrollment_count":3605,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05936502","title":"Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":3500,"lead_sponsor_name":"Head and Neck Cancer International Group","has_results":false},{"nct_id":"NCT04927650","title":"Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening","phase":"","overall_status":"RECRUITING","enrollment_count":3200,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05247853","title":"HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV","phase":"","overall_status":"COMPLETED","enrollment_count":3127,"lead_sponsor_name":"Montefiore Medical Center","has_results":false},{"nct_id":"NCT03709602","title":"SDH of HPV Vaccine Completion","phase":"","overall_status":"COMPLETED","enrollment_count":3076,"lead_sponsor_name":"Duke University","has_results":true},{"nct_id":"NCT05662020","title":"A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2750,"lead_sponsor_name":"Beijing Health Guard Biotechnology, Inc","has_results":false},{"nct_id":"NCT04783649","title":"Clinical Validation of Cervical Cancer Screening Methods","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"N.N. Petrov National Medical Research Center of Oncology","has_results":false},{"nct_id":"NCT03898167","title":"Prospective Evaluation of Self-Testing to Increase Screening","phase":"NA","overall_status":"COMPLETED","enrollment_count":2474,"lead_sponsor_name":"Baylor College of Medicine","has_results":true},{"nct_id":"NCT06708351","title":"Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2280,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT06598475","title":"Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents","phase":"NA","overall_status":"RECRUITING","enrollment_count":2142,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT04000503","title":"Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2019,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06926062","title":"Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1900,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT07104240","title":"A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":1836,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT06786429","title":"Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":1800,"lead_sponsor_name":"Eunice Dube","has_results":false},{"nct_id":"NCT00092547","title":"A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1781,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}